MAPT and primary progressive aphasia: These findings are surprising since the vast majority of SV PPA patients have underlying TDP-43 proteinopathy [5] and are not expected to show [18F]AV1451 binding in the anterior temporal lobe as the ligand has selectivity for tau over amyloid (29 fold) [7].